📰 Phase 2 3 News
Phase 2 3 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phase 2 3. Real-time updates on events, politics, business and more.
April 25, 2024
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or...
October 12, 2023
Shares of Annovis Bio, Inc. (ANVS) are up 16% on Thursday after the company shared positive news about its Alzheimer's study. ANVS is trading on the New York Stock Exchange at $9.
April 2, 2023
Finding a treatment for a skin disease that significantly diminishes the quality of life for those living with it has moved forward to the next phase of trials.
March 30, 2023
Finding a treatment for a skin disease that significantly diminishes the quality of life for those living with it has moved forward to the next phase of trials.